Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA Injection.

Abstract

Chronic pelvic pain (CPP) is defined as pain in the pelvic organs and related structures of at least 6 months' duration. The pathophysiology of CPP is uncertain, and its treatment presents challenges. Botulinum toxin A (BoNT-A), known for its antinociceptive, anti-inflammatory, and muscle relaxant activity, has been used recently to treat refractory CPP with promising results. In patients with interstitial cystitis/bladder pain syndrome, most studies suggest intravesical BoNT-A injection reduces bladder pain and increases bladder capacity. Repeated BoNT-A injection is also effective and reduces inflammation in the bladder. Intraprostatic BoNT-A injection could significantly improve prostate pain and urinary frequency in the patients with chronic prostatitis/chronic pelvic pain syndrome. Animal studies also suggest BoNT-A injection in the prostate decreases inflammation in the prostate. Patients with CPP due to pelvic muscle pain and spasm also benefit from localized BoNT-A injections. BoNT-A injection in the pelvic floor muscle improves dyspareunia and decreases pelvic floor pressure. Preliminary studies show intravesical BoNT-A injection is useful in inflammatory bladder diseases such as chemical cystitis, radiation cystitis, and ketamine related cystitis. Dysuria is the most common adverse effect after BoNT-A injection. Very few patients develop acute urinary retention after treatment.

• Authors: Jia-Fong Jhang, Hann-Chorng Kuo
• Journal: Toxins (Toxins (Basel)) Vol. 7 Issue 6 Pg. 2232-50 (Jun 18 2015) ISSN: 2072-6651 [Electronic] Switzerland
• PMID: 26094697 (Publication Type: Journal Article, Review)

Chemical References

• Analgesics
• Anti-Inflammatory Agents
• Botulinum Toxins, Type A

Topics

• Analgesics (adverse effects, therapeutic use)
• Animals
• Anti-Inflammatory Agents (adverse effects, therapeutic use)
• Botulinum Toxins, Type A (adverse effects, therapeutic use)
• Chronic Pain (drug therapy)
• Humans
• Pelvic Floor Disorders (drug therapy)
• Somatoform Disorders (drug therapy)
• Syndrome
• Urologic Diseases (drug therapy)